Ушбу иш иқтибос қилган ишлар

292 та иш

Иш: Nanoparticle-Based PCSK9 Inhibition in Viral Infections: Evaluating Clinical Limitations and Advancing Therapeutic Strategies

The effect of surface charge on oral absorption of polymeric nanoparticles
Xiao‐Jiao Du, Jilong Wang, Shoaib Iqbal +5
Мақола20182 иқтибос
ABI
Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines
Eugenia D. Namiot, Aleksandr V. Sokolov, Vladimir N. Chubarev +2
Шарҳ мақола20232 иқтибос
ABI
Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment
Karthikeyan Elumalai, Sivaneswari Srinivasan, Shanmugam Anandakumar
Мақола20232 иқтибос
ABI
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
Marianne Abifadel, Mathilde Varret, Jean‐Pierre Rabès +23
Мақола20032 иқтибос
ABI
Sequence Variations in <i>PCSK9,</i> Low LDL, and Protection against Coronary Heart Disease
Jonathan C. Cohen, Eric Boerwinkle, Thomas H. Mosley +1
Мақола20062 иқтибос
ABI
The <i>PCSK9</i> gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men
Mariléia Scartezini, Christina Hubbart, Ros Whittall +3
Мақола20072 иқтибос
ABI
Advances in the Omicron variant development
Antonio Vitiello, Francesco Ferrara, Amogh Auti +2
Шарҳ мақола20222 иқтибос
ABI
Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects
Sutapa Barua, Samir Mitragotri
Шарҳ мақола20142 иқтибос
ABI
The Future of Drug Delivery
Jingjing Gao, Jeffrey M. Karp, Róbert Langer +1
Мақола20232 иқтибос
ABI
A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system
Saman Yasamineh, Pooneh Yasamineh, Hesam Ghafouri Kalajahi +8
Шарҳ мақола20222 иқтибос
ABI
Nanotechnology-based approaches for targeted drug delivery for the treatment of respiratory tract infections
Vasiliki Georgakopoulou, Petros Papalexis, Νικόλαος Τράκας
Шарҳ мақола20242 иқтибос
ABI
Clinical Translation of Extracellular Vesicles
Aayushi Ghodasara, Aun Raza, Joy Wolfram +2
Мақола20232 иқтибос
ABI
SARS-CoV-2 Omicron variant: recent progress and future perspectives
Yao Fan, Xiang Li, Lei Zhang +3
Шарҳ мақола20222 иқтибос
ABI
Prevalence and predictors of dyslipidemia among HAART treated and HAART naive HIV positive clients attending Debre Tabor Hospital, Debre Tabor, Ethiopia
Anemut Tilahun, Endeshaw Chekol Abebe, Awgchew Behaile Teklemaryam +10
Мақола20222 иқтибос
ABI
Preclinical testing of antiviral siRNA therapeutics delivered in lipid nanoparticles in animal models – a comprehensive review
Yusuf M. Idres, Adi Idris, Wenqing Gao
Шарҳ мақола20252 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI